Search for: "carl" Results 461 - 480 of 8,510
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
[...] the presentation, Tom Bruce of the Legal Information Institute at the Cornell University Law School, and Carl Malamud of Public.Resource.Org discuss these principles with workshop [...] [read post]
19 Sep 2011, 4:57 pm by Rick Hasen
The Carl Lewis court will hear arguments on this and other questions tomorrow morning in an unusual rehearing. [read post]
24 Nov 2009, 9:51 pm
Follow up to previous postings on Google Book Search (GBS), Google and the New Digital Future, Robert Darnton is Carl... [read post]
13 Aug 2012, 4:00 pm
Carl Hodgetts has been paralysed from the waist down since birth due to spina bifida. [read post]
28 Jul 2010, 10:47 am by By STEVEN M. DAVIDOFF
The Deal Professor examines the legal action that Carl C. [read post]
12 Mar 2010, 8:21 am by Marcia Oddi
The only writeup the ILB has seen of the March 9, 2010 decision by Judge Carl Heldt is in The... [read post]
9 May 2025, 7:26 am by tortsprof
At JOTWELL, Carl Coleman reviews Omer Pelled's Aggregating Liability for Medical Malpractice. [read post]
13 Jun 2021, 10:00 pm
Partner Carl Valenstein authored a column for Pharmaceutical Executive about environmental, social, and governance (ESG) trends in the biopharma sector. [read post]
18 Sep 2008, 12:54 pm
"Why the Senate Needs to Approve More Judges Before It Adjourns": Carl Tobias has this essay online at FindLaw. [read post]
11 Oct 2010, 10:01 am by Sabrina
Unclassified White House Report to Congress on Afghanistan and Pakistan, addressed to Senator Carl Levin, Chairman, Armed Services Committee, September... [read post]
10 Aug 2012, 11:12 am
Subcommittee Chairman Carl Levin ,D-MI, questions Daniel Sparks, a former Goldman Sachs partner... [read post]
31 Jul 2015, 10:55 am
"Confirm Judge Restrepo": Law professor Carl Tobias has this essay online at The Pittsburgh Tribune-Review. [read post]
13 Jun 2021, 10:00 pm
Partner Carl Valenstein authored a column for Pharmaceutical Executive about environmental, social, and governance (ESG) trends in the biopharma sector. [read post]